Sagent - Top 15 Biotech VC Deals of 2010

Company: Sagent Pharmaceuticals
Based: Schaumberg, IL
Amount: $40M

Investors: Zhejiang Hisun Pharmaceutical and other undisclosed partners 

Scoop: Sagent has set its sights firmly on China as it received $10 million from Zhejiang Hisun Pharmaceutical and another $30 million from "an unnamed China-focused private equity investment fund," according to a company release.

Sagent made 2007's VC list after a $53 million venture round. The company has raised $153 million total.

Sagent - Top 15 Biotech VC Deals of 2010

Suggested Articles

Versantis will use the €16 million to trial a drug designed to remove toxic metabolites from liver disease patients.

The Merck-backed round positions Themis to take its chikungunya vaccine through phase 3 and start testing a cancer drug in humans.

No biohazardous substances were in the room where the explosion happened, according to the Russian virology center.